Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Alzheimers Dis ; 80(3): 1067-1077, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33646167

RESUMO

BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia and biomarkers are essential to help in the diagnosis of this disease. Image techniques and cerebrospinal fluid (CSF) biomarkers are limited in their use because they are expensive or invasive. Thus, the search for blood-borne biomarkers is becoming central to the medical community. OBJECTIVE: The main objective of this study is the evaluation of three serum proteins as potential biomarkers in AD patients. METHODS: We recruited 27 healthy controls, 19 mild cognitive impairment patients, and 17 AD patients. Using the recent A/T/N classification we split our population into two groups (AD and control). We used ELISA kits to determine Aß42, tau, and p-tau in CSF and clusterin, PKR, and RAGE in serum. RESULTS: The levels of serum clusterin, PKR, and RAGE were statistically different in the AD group compared to controls. These proteins showed a statistically significant correlation with CSF Aß42. So, they were selected to generate an AD detection model showing an AUC-ROC of 0.971 (CI 95%, 0.931-0.998). CONCLUSION: The developed model based on serum biomarkers and other co-variates could reflect the AD core pathology. So far, not one single blood-biomarker has been described, with effectiveness offering high sensitivity and specificity. We propose that the complexity of AD pathology could be reflected in a set of biomarkers also including clinical features of the patients.


Assuntos
Doença de Alzheimer/sangue , Antígenos de Neoplasias/sangue , Biomarcadores/sangue , Clusterina/sangue , Proteínas Quinases Ativadas por Mitógeno/sangue , eIF-2 Quinase/sangue , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/líquido cefalorraquidiano , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
2.
In Vivo ; 34(3 Suppl): 1645-1650, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32503824

RESUMO

BACKGROUND/AIM: A novel human coronavirus, named SARS-COV-2, has recently caused thousands of deaths all around the world. Endoplasmic reticulum (ER) stress plays an important role in the development of diseases. PATIENTS AND METHODS: We aimed to to investigate the relationship between ER stress markers in patients infected with SARS-COV-2 and patients with pneumonia. A total of 9 patients (4 patients diagnosed with pneumonia and 5 patients diagnosed with SARS-COV-2 infection) who admitted to the emergency Department with symptoms of pneumonia and SARS-COV-2 were included in the study. A total of 18 healthy individuals without any known chronic or acute disease and drug use were included as the healthy control group. Serum human glucose regulated protein 78 (GRP78), serum human C/EBP homologous protein (CHOP) and serum human phospho extracellular signal regulated kinase (PERK) levels were measured using enzyme-linked immunosorbent assay (ELISA). RESULTS: GRP78 levels were found to be significantly higher in SARS-COV-2 positive cases compared to individuals in other groups. Serum GRP-78 level median value was statistically significantly higher in SARS-COV-2-positive group compared to the other groups (p=0.0003). Serum PERK level was statistically significantly higher in SARS-COV-2-positive pneumonia cases (p=0.046). CONCLUSION: An association was shown between GRP78 and SARS-COV-2 infection. Although a small number of patients was investigated, these results will be important and guide future treatments of SARS-COV-2.


Assuntos
Infecções por Coronavirus/sangue , Estresse do Retículo Endoplasmático , Proteínas de Choque Térmico/sangue , Pneumonia Viral/sangue , Pneumonia/sangue , Biomarcadores , COVID-19 , Estudos de Casos e Controles , Infecções por Coronavirus/diagnóstico por imagem , Chaperona BiP do Retículo Endoplasmático , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pandemias , Pneumonia/diagnóstico por imagem , Pneumonia Viral/diagnóstico por imagem , Fator de Transcrição CHOP/sangue , eIF-2 Quinase/sangue
3.
Immunol Invest ; 48(3): 211-221, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30080984

RESUMO

BACKGROUND: RNA-dependant protein kinase R (PKR) is a primary mediator in the defence mechanism of interferon against viral replication and pathogenesis during Hepatitis C virus (HCV) infection. In the present study, we have examined the role of Single Nucleotide Polymorphisms (SNPs) in the promoter region of PKR and the serum level of the same protein on the outcome of HCV-infected Egyptian patients. PATIENTS AND METHODS: Genomic DNA was extracted from a total of 135 subjects, including 15 healthy controls, 40 HCV spontaneous resolvers (SRs), and 80 patients with chronic HCV infection. PKR genotyping was assessed using DNA sequencing. Finally, serum levels of PKR, TNF-α, INF-γ, and IL-10 were measured using ELISA technique. RESULTS: Serum levels of PKR, TNF-α, and INF-γ showed a significant increase in SRs as compared to chronic HCV patients. On the other hand, serum levels of IL-10 were significantly higher in chronic HCV patients compared to SRs. The present study demonstrated two novel SNPs in the PKR promoter region: at -226 C/T and -141 C/G. The PKR SNP at -226 C < T correlated with HCV-infected patients (genotype 4a) outcome among Egyptians. Our data showed the unique presence of the TT genotype in SRs group (three patients: 7.5%) in PKR -226 C/T. Interestingly, subjects with the TT genotype were more likely to clear their HCV infection than those with the CC genotype. CONCLUSION: Our work provides more detail about PKR gene polymorphism in HCV genotype 4a as a new clinical tool for anticipating HCV-4a infection outcome.


Assuntos
Hepacivirus/imunologia , Hepatite C Crônica/sangue , eIF-2 Quinase/genética , Adolescente , Adulto , Biomarcadores/sangue , Estudos de Casos e Controles , Egito , Feminino , Genótipo , Hepacivirus/isolamento & purificação , Hepatite C Crônica/imunologia , Hepatite C Crônica/virologia , Humanos , Interferon-alfa/imunologia , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Regiões Promotoras Genéticas/genética , Remissão Espontânea , Adulto Jovem , eIF-2 Quinase/sangue
4.
Biochem J ; 471(3): 357-67, 2015 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-26303523

RESUMO

An imbalance in pro- and anti-inflammation is an important mechanism of steroid resistance in UC (ulcerative colitis), and miRNAs may participate in this process. The present study aimed to explore whether miRNAs play a role in the steroid resistance of UC by regulating gene expression of the inflammation signal pathway. SS (steroid-sensitive) patients, SR (steroid-resistant) patients and healthy individuals were recruited. In vivo miRNA profiles of serum samples showed that miR-195 was decreased significantly in the SR group compared with the SS group (P<0.05). This result was confirmed by qPCR (quantitative real-time PCR) and miRNA ISH (in situ hybridization) in serum and colon tissue samples. Online software was used to identify Smad7 mRNA as a potential target of miR-195. The direct interaction of miR-195 and Smad7 mRNA was investigated using a biotinylated miR-195 pull-down assay. Overexpression of a miR-195 precursor lowered cellular levels of Smad7 protein; conversely, antagonism of miR-195 enhanced Smad7 translation without disturbing Smad7 mRNA levels. A luciferase reporter assay revealed a repressive effect of miR-195 via a single Smad7 3'-UTR target site, and point mutation of this site prevented miR-195-induced repression of Smad7 translation. Furthermore, increased levels of miR-195 led to a decrease in c-Jun and p65 expression. In contrast, transfection with anti-miR-195 led to increased levels of c-Jun and p65 protein. The decrease in miR-195 led to an increase in Smad7 expression and corresponding up-regulation of p65 and the AP-1 (activator protein 1) pathway, which might explain the mechanism of steroid resistance in UC patients.


Assuntos
Colite Ulcerativa/genética , Resistência a Medicamentos/genética , MicroRNAs/genética , Proteína Smad7/genética , Esteroides/uso terapêutico , Regiões 3' não Traduzidas , Adulto , Células CACO-2 , Colite Ulcerativa/sangue , Colite Ulcerativa/tratamento farmacológico , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , MicroRNAs/biossíntese , MicroRNAs/sangue , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas c-jun/biossíntese , Proteínas Proto-Oncogênicas c-jun/sangue , Transdução de Sinais/genética , Proteína Smad7/biossíntese , Proteína Smad7/sangue , Fator de Transcrição AP-1/biossíntese , Fator de Transcrição AP-1/sangue , eIF-2 Quinase/biossíntese , eIF-2 Quinase/sangue
5.
Blood ; 109(7): 2693-9, 2007 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-17110456

RESUMO

During erythroid differentiation and maturation, it is critical that the 3 components of hemoglobin, alpha-globin, beta-globin, and heme, are made in proper stoichiometry to form stable hemoglobin. Heme-regulated translation mediated by the heme-regulated inhibitor kinase (HRI) provides one major mechanism that ensures balanced synthesis of globins and heme. HRI phosphorylates the alpha-subunit of eukaryotic translational initiation factor 2 (eLF2alpha) in heme deficiency, thereby inhibiting protein synthesis globally. In this manner, HRI serves as a feedback inhibitor of globin synthesis by sensing the intracellular concentration of heme through its heme-binding domains. HRI is essential not only for the translational regulation of globins, but also for the survival of erythroid precursors in iron deficiency. Recently, the protective function of HRI has also been demonstrated in murine models of erythropoietic protoporphyria and beta-thalassemia. In these 3 anemias, HRI is essential in determining red blood cell size, number, and hemoglobin content per cell. Translational regulation by HRI is critical to reduce excess synthesis of globin proteins or heme under nonoptimal disease states, and thus reduces the severity of these diseases. The protective role of HRI may be more common among red cell disorders.


Assuntos
Anemia/sangue , Proteínas Sanguíneas/biossíntese , eIF-2 Quinase/sangue , Anemia Hipocrômica/sangue , Anemia Ferropriva/sangue , Animais , Ativação Enzimática , Eritropoese , Heme/deficiência , Heme/metabolismo , Humanos , Camundongos , Modelos Biológicos , Protoporfiria Eritropoética/sangue , Transdução de Sinais , Talassemia beta/sangue
6.
Clin Gastroenterol Hepatol ; 3(5): 499-506, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15880320

RESUMO

BACKGROUND & AIMS: Black American patients are less likely to eradicate hepatitis C virus (HCV) infections during treatment with peginterferon (PEG-IFN) and ribavirin. We hypothesized that racial differences in IFN-stimulated antiviral gene induction during treatment might be responsible. METHODS: We examined myxovirus resistance-A (MxA), RNA-dependent protein kinase (PKR), 2'-5' oligoadenylate synthetase (2,5-OAS), and adenosine deaminase-1 (ADAR1) gene expression in the peripheral blood mononuclear cells (PBMCs) of 31 black and 11 white HCV genotype 1 patients at baseline and at weeks 4-12 during PEG-IFN alfa-2a combination treatment. The primary study end point was the early virologic response (EVR)-either an undetectable serum HCV-RNA level or a > or =2-log decrease in serum HCV-RNA level at week 12 compared with week 0. RESULTS: The EVR rate was 67.7% in blacks and 63.6% in whites. Both blacks and whites experienced a significant (200%-500%) increase in 2,5-OAS, MxA, PKR, and ADAR1 expression at treatment weeks 4-12 compared with baseline (P < .01). However, the relationship between IFN-stimulated gene expression and the EVR differed by race. White responders exhibited higher 2,5-OAS and MxA levels at week 4 than white nonresponders (P < .05). IFN-stimulated gene levels did not correlate with EVR in blacks. Black responders had much lower MxA and PKR levels at week 4 than black nonresponders (P < .05). However, black responders maintained increased 2,5-OAS, MxA, and PKR levels from weeks 4-12, whereas the levels decreased to baseline at weeks 8-12 in black nonresponders. CONCLUSIONS: The mechanisms of resistance to PEG-IFN combination therapy may be different in black and white HCV genotype 1 patients.


Assuntos
Antivirais/uso terapêutico , População Negra/genética , Hepatite C Crônica/genética , Interferon-alfa/uso terapêutico , Polietilenoglicóis/uso terapêutico , População Branca/genética , 2',5'-Oligoadenilato Sintetase/sangue , 2',5'-Oligoadenilato Sintetase/genética , Adenosina Desaminase/sangue , Adenosina Desaminase/genética , Adulto , Quimioterapia Combinada , Feminino , Proteínas de Ligação ao GTP/sangue , Proteínas de Ligação ao GTP/genética , Expressão Gênica , Genótipo , Hepatite C Crônica/sangue , Hepatite C Crônica/tratamento farmacológico , Humanos , Interferon alfa-2 , Masculino , Pessoa de Meia-Idade , Proteínas de Resistência a Myxovirus , Estudos Prospectivos , RNA Viral/sangue , Proteínas Recombinantes , Ribavirina/uso terapêutico , eIF-2 Quinase/sangue , eIF-2 Quinase/genética
7.
Acta Med Okayama ; 57(5): 217-25, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14679399

RESUMO

To improve the efficacy of interferon (IFN) treatment for chronic hepatitis C, we have proposed the twice-daily administration of IFN-beta as a promising induction therapy. In this study, we demonstrated differences between the clearance of circulating HCV-RNA and the induction of anti-viral actions during the first 2 weeks of treatment. Nine patients with a high viral load and genotype 1b were randomly assigned to 3 groups: group A received 3MU of IFN-beta twice a day at intervals of 5 and 19 h; group B received 3MU of IFN-beta twice a day at intervals of 10 and 14 h; group C received 6MU of IFN-alpha once a day with ribavirin. The expression of OAS2, PKR, and MxA in peripheral blood mononuclear cells (PBMCs) were quantified by real-time polymerase chain reaction method. The viral clearance showed a bi-phasic pattern, and those in the second phase of groups A and B were significantly steeper than that of group C. The peak level of OAS2 during the first phase was correlated with the first phase decay. The MxA expression tended to be higher in group A and B than in group C. The expression of these 3 proteins tended to decrease at day 6 in group C, but increase in groups A and B. These might make differences in the viral decay during the second phase


Assuntos
Antivirais/administração & dosagem , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/administração & dosagem , Interferon beta/administração & dosagem , RNA Viral/sangue , Ribavirina/administração & dosagem , 2',5'-Oligoadenilato Sintetase/sangue , 2',5'-Oligoadenilato Sintetase/genética , Adulto , Esquema de Medicação , Quimioterapia Combinada , Feminino , Proteínas de Ligação ao GTP/sangue , Proteínas de Ligação ao GTP/genética , Expressão Gênica , Hepacivirus/genética , Hepatite C Crônica/sangue , Hepatite C Crônica/virologia , Humanos , Cinética , Masculino , Pessoa de Meia-Idade , Monócitos/metabolismo , Proteínas de Resistência a Myxovirus , Fatores de Tempo , eIF-2 Quinase/sangue , eIF-2 Quinase/genética
8.
Biotechnol Appl Biochem ; 36(1): 57-62, 2002 08.
Artigo em Inglês | MEDLINE | ID: mdl-12149123

RESUMO

The haem-regulated eukaryotic initiation factor 2alpha kinase, also called the haem-regulated inhibitor (HRI), has been shown to increase in the peripheral blood cells as a function of drug-induced anaemia in rabbits, suggesting that it could be a molecular indicator of drug-induced anaemia [Anand and Pal (1997) J. Biosci. 22, 287-298]. In the present investigation, we have determined the expression of HRI during lead-induced anaemia in rabbits. The level of anaemia has been determined by routine procedures such as reticulocyte count, haemoglobin content and packed cell volume. These values were compared with the results obtained for a quantitative Western blot of HRI in the blood cell lysates of drug- and lead-induced anaemic rabbits. These results indicate that HRI could be used as a molecular marker for lead-induced anaemia since a progressive increase in HRI levels could be detected as a function of the time of lead exposure. In order to understand the role of stress proteins, heat-shock protein (Hsp) 70 and Hsp90, in inducing anaemia during lead exposure, levels of Hsp70 and Hsp90, and their interaction with HRI, have been determined. Increased levels of these proteins and their intermolecular complexes with HRI suggest their role in regulating protein synthesis during lead-induced anaemia. These observations further reiterate the use of HRI as a potential indicator for drug- and heavy-metal-induced anaemia in humans.


Assuntos
Anemia/metabolismo , Biomarcadores/sangue , Proteínas de Choque Térmico/metabolismo , Heme/metabolismo , eIF-2 Quinase/metabolismo , Anemia/induzido quimicamente , Animais , Proteínas de Choque Térmico/sangue , Compostos Organometálicos/administração & dosagem , Compostos Organometálicos/efeitos adversos , Coelhos , Valores de Referência , eIF-2 Quinase/sangue
9.
Immunopharmacol Immunotoxicol ; 21(2): 175-202, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10319275

RESUMO

Overlapping symptomatologies between Chronic Fatigue Syndrome (CFS) and Chemical Sensitivity have been observed by different investigators. Therefore, it is of great importance to develop biomarker(s) for possible differentiation between viral induced CFS (without sensitivity to chemicals) versus chemically induced CFS. Since interferon induced proteins 2-5A Synthetase and Protein Kinase RNA (PKR) have been implicated in the viral induction of CFS, the objective of this study was to utilize 2-5A and PKR activity for differentiation between CFS induced by either viruses or chemicals. Based on the CDC definition and criteria, twenty CFS patients who were positive for viral genome(s) (mainly HHV6; HTLVII, EBV, and CMV) and did not have any history of exposure to toxic chemicals were included in this study. As a comparison, the second group of patients consisted of twenty individuals from the same geographical area who were negative for viral genomes but had been exposed to methyl tertiary-butyl ether concentration of up to 70 ppb and benzene concentration up to 14 ppb. All patients complained of fatigue and other symptoms overlapping between the two groups. From all 40 patients, blood was drawn, leukocyte extract was prepared and assayed for 2-5A Synthetase and PKR activity. Clinical specimens which were positive for viral genomes showed from 2.2-38.7 fold increase in 2-5A activity and 1.3-13.5 fold increase in PKR activities over the background of the healthy controls. Similarly, the second group (negative for viral genomes, but exposed to chemicals) showed a 1.1-29.2 fold increase for 2-5A Synthetase and a 1.3-11.6 fold increase for PKR when they were compared to healthy subjects. To elucidate mechanisms involved in viral versus chemical induction of 2-5A Synthetase and PKR, MDBK cell lines were cultured either in the presence or absence of HHV6, MTBE, or Benzene, heat shock proteins and interferon-beta. 2-5A and PKR activities were measured in all the above conditions. A clear induction of 2-5A and PKR was observed when MDBK cells were exposed to HHV6, MTBE, and Benzene. This induction was more significant with HSP90, HSP70, and IFN-beta indicating their involvement in the mechanism of action. However, when MDBK cells were incubated either with MTBE + Benzene or HHV6 in the presence or absence of anti IFN-beta or anti-HSP-70, the activities of both 2-5A and PKR in HHV6 infected cells were inhibited by more than 90% due to addition of anti IFN-beta, and only 20% by addition of anti-HSP70. While in MTBE + Benzene exposed cells anti IFN-beta reduced the activity of these enzymes by 40% and anti-HSP70 by more than 90%. This variation in the induction of 2-5A and PKR by anti-HSP70 or IFN-beta indicates involvement of IFN-beta in viral induction 2-5A and PKR, and HSP involvement in chemical induction of these enzymes. We conclude that 2-5A and PKR are not only biomarkers for viral induction of CFS, but biomarkers to other stressors that include MTBE and Benzene.


Assuntos
2',5'-Oligoadenilato Sintetase/sangue , Benzeno/toxicidade , Síndrome de Fadiga Crônica/etiologia , Interferons/fisiologia , Éteres Metílicos/toxicidade , Viroses/complicações , eIF-2 Quinase/sangue , Adulto , Animais , Biomarcadores , Síndrome de Fadiga Crônica/imunologia , Feminino , Herpesvirus Humano 4/isolamento & purificação , Herpesvirus Humano 6/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade
10.
Exp Cell Res ; 238(1): 273-82, 1998 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-9457081

RESUMO

Changes in the expression of the heme-regulated eIF-2 alpha kinase (HRI), heat shock proteins (Hsps, Hsp90, and 70) and their associated cohorts (p60 and p23) were studied in maturing rabbit reticulocytes during recovery from anemia. Reticulocytosis was induced by injection of N-acetylphenylhydrazine or by phlebotomy from the ear vein, and circulating red blood cells were fractionated on histopaque density gradients. Northern and Western blot analyses indicated that HRI and hsps mRNA and protein content gradually decreased during maturation of reticulocytes into erythrocytes. Reduction in levels of hsps and HRI was also observed when cells of same age group (density) were compared as the animals recovered from the anemia. Low hematocrits correlated with high levels of hsps expression and with increasing hematocrits hsps expression decreased. Under the conditions used to quantify these protein levels, Hsc70 and p60 were detected in erythrocytes of fully recovered animals. Maintenance of Hsc70 and p60 suggests important ongoing roles for these hsps in protecting the structure and function of proteins in erythrocytes lacking transcriptional and translational machinery.


Assuntos
Anemia/sangue , Proteínas de Choque Térmico/biossíntese , Reticulócitos/fisiologia , eIF-2 Quinase/biossíntese , Animais , Envelhecimento Eritrocítico , Proteínas de Choque Térmico/sangue , RNA Mensageiro/sangue , Coelhos , Fatores de Tempo , Transcrição Gênica , eIF-2 Quinase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...